Pharmachol Chemicals Profile
Key Indicators
- Authorised Capital ₹ 31.50 Cr
as on 13-12-2024
- Paid Up Capital ₹ 31.09 Cr
as on 13-12-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -32.39%
(FY 2020)
- Profit -59.19%
(FY 2020)
- Ebitda -103.00%
(FY 2020)
- Net Worth 2.76%
(FY 2020)
- Total Assets 3.30%
(FY 2020)
About Pharmachol Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 31.50 Cr and a paid-up capital of Rs 31.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pharmachol Chemicals Private Limited India is Sweety Jhunjhunwala as COMPANY SECRETARY. Kuldip Kapoor and Nagarajan Karthik serve as directors at the Company.
- CIN/LLPIN
U36100HR2016PTC058478
- Company No.
058478
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pharmachol Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sweety Jhunjhunwala | Company Secretary | 16-Aug-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuldip Kapoor  | Director | 27-Jun-2019 | Current |
| Nagarajan Karthik | Director | 15-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Pharmachol Chemicals.
Pharmachol Chemicals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 32.39% decrease. The company also saw a substantial fall in profitability, with a 59.19% decrease in profit. The company's net worth moved up by a moderate rise of 2.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmachol Chemicals?
In 2019, Pharmachol Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kumbakonam Mutual Benefit Fund Nidhi LimitedActive 121 years 20 daysSweety Jhunjhunwala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmachol Chemicals?
Unlock and access historical data on people associated with Pharmachol Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmachol Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmachol Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
